Biosensors International - Biofreedom Drug Coated Coronary Stent

  Out-of-Stock 

Purchase at Moment

Payment After 3 Month

Quarterly repayment with the lowest fees Recharge every three months, 200 million tomman for each season.

Features:

Drug - Coated Coronary Stent

Singapore Made

Biolimus A9

Decrease of Bleeding Risk

 
Notify me when available

  • 0
  • Out stock
  • Free

Pay in installments

Choose your plan:

Current plan: 3Month

Description: 30+3

Down payment: $0.00 (25.00%)

Number of payments: 3

Tax: $0.00

Amount of payment: $0.00

Overpayment: $0.00

Total: $0.00

Current plan: Cash

Description: نقدی

Down payment: $0.00 (0.00%)

Number of payments: 1

Tax: $0.00

Amount of payment: $0.00

Overpayment: $0.00

Total: $0.00

Description

Biofreedom Drug Coated Coronary Stent

The combination of a selectively micro-structured abluminal surface (SMS) and Biolimus A9™ make BioFreedom a unique stent. At least 20% of PCI patients are High Bleeding Risk (HBR) requiring an individualized approach, BioFreedom provides a more appropriate treatment strategy.

The rapid 28 day transfer of BA9 to the coronary artery and rapid reendothelialization of the stented vessel, make BioFreedom the most relevant choice of stent for High Bleeding Risk (HBR) patients who cannot tolerate long dual antiplatelet therapy (DAPT).

The LEADERS FREE trial proved superior safety and efficacy of the BioFreedom DCS vs a BMS in the previously understudied and underserved HBR patient population.

 

SignificantlySafer than BMS

29% Reduction in the Rate of the Compositeof Cardiac Death, MI, ST 

 

Significantly moreEffective than BMS

50% Reduction in the Rate of Restenosis

 

SMS, Selectively MicrostructuredSurface

Only the abluminal surface of the stent receives SMS treatment, allowing BA9 to be contained on themicrostructuredsurface and delivered with high specificity to the vessel wall of the coronary lesions.

With no need for polymer or carrier, BA9 and SMS make BioFreedom a true Drug-Coated Stent (DCS).

 

The SMS process allows for an increased surface area for a uniformdose of BA9 to be delivered to the target lesion.

 

BIOSENSORS INTERNATIONAL GROUP LTD - Biofreedom Drug Coated Coronary Stent

  

The Spesification of  Biofreedom Drug - Coated Stent in Comparison with Other Stents

 

BIOSENSORS INTERNATIONAL GROUP LTD - Biofreedom Drug Coated Coronary Stent



Reference : 0

Data sheet

  • Biosensors International

Specific References

New product



Leave a comment about this product

Write your review

Write your review

Biosensors International - Biofreedom Drug Coated Coronary Stent

Write your review